Trials / Conditions / Malabsorption Syndromes

Malabsorption Syndromes

12 registered clinical trials studyying Malabsorption Syndromes — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Long-term Health Outcomes of Screen Detected and Potential Celiac Disease Patients NCT07366151	Tampere University Hospital	—
Recruiting	Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) NCT06904872	Napo Therapeutics, S.p.A.	Phase 2
Recruiting	Immune Responses to Gluten NCT05209568	Boston Children's Hospital	N/A
Unknown	A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) NCT03644069	ImmusanT, Inc.	Phase 2
Completed	Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease NCT03543540	ImmusanT, Inc.	Phase 1
Suspended	Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease NCT03462979	Boston Children's Hospital	N/A
Completed	Vitamin D Substitution for Patients With Chronic Pancreatitis and Malabsorption NCT01141998	Hvidovre University Hospital	N/A
Completed	A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic NCT00662675	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients NCT00138879	St Mark's Hospital Foundation	—
Completed	Plasma Citrulline Concentration in Tropical Enteropathy NCT00816842	Azienda Ospedaliero-Universitaria di Parma	—
Completed	Validation of Breath Tests in Diagnosing Small Bowel Bacterial Overgrowth NCT00872092	University Hospital, Bonn	—
Unknown	The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study NCT00163813	Bayside Health	N/A